Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Bacil Pharma Ltd.

NSE : BSE : 524516 ISIN CODE : INE711D01018Industry : Pharmaceuticals

News

  • Bacil Pharma - Receipt Of Listing Approval Granted By Stock Exchange For 84,63,000 Equity Shares Of Rs.10/- Each Issued At A 05 Jun 2025 | 19:21 | Dion Global

    As per Attachmentmore...

  • Bacil Pharma - Revised Audited Financial Result For The Quarter And Year Ended 31St March, 2025 26 May 2025 | 20:25 | Dion Global

    Revised Audited Financial Result for the Quarter and Year ended 31st March 2025more...

  • Bacil Pharma - Revised Outcome Of Board Meeting Held On 26Th May, 2025 For Audited Financial Result For The Quarter And Year 26 May 2025 | 20:15 | Dion Global

    Revised Outcome of Board Meeting held on 26th May 2025 for Audited Financial Result for the Quarter and Year ended 31st March 2025more...

  • Bacil Pharma - Results-Financial Results For The Year Ended 31/03/2025 26 May 2025 | 17:58 | Dion Global

    Audited Financial Results for the year ended 31st March 2025more...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Audited Financials For The Year Ended 31St 26 May 2025 | 17:46 | Dion Global

    Outcome of Board Meeting for Approval of Audited Financials for the year ended 31st March 2025more...

  • Bacil Pharma - Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Sc 17 May 2025 | 18:20 | Dion Global

    Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider...more...

  • Bacil Pharma - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 23 Apr 2025 | 17:26 | Dion Global

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bacil Pharma L...more...

  • Bacil Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 23 Apr 2025 | 17:21 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bacil Ph...more...

  • Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025 21 Apr 2025 | 20:00 | Dion Global

    As of March 2025 0.20% is owned by Indian Promoters and 99.80% by Public. Top two Promoters holding highest number of shares of Bacil Pharma company ...more...

  • Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr 2025 | 16:58 | Dion Global

    Compliance Certificate under Reg 74(5) of SEBI (DP) Regulationmore...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Preferential Allotment Committee ('The Committee') Held On 24Th March 24 Mar 2025 | 21:01 | Dion Global

    Outcome of the Preferential Allotment Committee ( the Committee ) held on 24th March \r\n2025 for Allotment of 8 62 500 equity shares to non-promoter...more...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Preferential Allotment Committee ('The Committee') Held On 24Th March 24 Mar 2025 | 21:01 | Dion Global

    Outcome of the Preferential Allotment Committee ( the Committee ) held on 24th March \r\n2025 for Allotment of 8 62 500 equity shares to non...more...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Allotment 24 Mar 2025 | 20:53 | Dion Global

    Outcome of preferential Allotment committee held on 24 th march 2025more...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Allotment 12 Mar 2025 | 20:37 | Dion Global

    Allotment of 65 80 500 equity shares to non promoter on a preferential basis.more...

  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Preferential Allotment Committee ('The Committee') Held On 12Th\r\nMa 12 Mar 2025 | 20:33 | Dion Global

    Outcome of the Preferential Allotment Committee ( the Committee ) held on 12th\r\nMarch 2025 for Allotment of 65 80 500 equity shares to non-promoter...more...

  • Bacil Pharma - In-Principle Approval Granted By Stock Exchange 11 Mar 2025 | 19:17 | Dion Global

    In-Principle approval granted by stock exchangemore...

  • Bacil Pharma - In-Principle Approval Granted By Stock Exchange 11 Mar 2025 | 18:22 | Dion Global

    In-Principle Approval granted by stock exchange for issue of the 15 62 500 equity shares to non-promoters on preferential basis for cash consideratio...more...

  • Bacil Pharma - Integrated Filing (Financial) 11 Mar 2025 | 13:38 | Dion Global

    Integrated Filing of Financialsmore...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Resignation of Director 25 Feb 2025 | 18:11 | Dion Global

    Resignation of Mr. Mehul Hasmukhbhai Shah from the position of Executive Directormore...

  • Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024 21 Jan 2025 | 18:50 | Dion Global

    As of December 2024 10.60% is owned by Indian Promoters and 89.40% by Public. Top five Promoters holding highest number of shares of Bacil P...more...

Enter Stock

DOW Jones42515.090.75%
Nasdaq19701.211.52%
S&P 5006033.110.94%
Nikkei 22538464.060.40%
Hang Seng24028.83-0.13%
Shanghai Composite3382.14-0.19%
Sensex81585.15-0.26%
NSE Index24890.35-0.23%
BSE 100LCTMC9198.68-0.19%
BSE Auto 52238.19-0.27%
BSE Bharat228575.480.04%
BSE CPSE 3932.30.26%

Commodity

Gold988580.13%
Silver1063270.39%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 86.02(-0.08 %)
GBP/INR 116.75(0.16 %)
EUR/INR 99.40(0.08 %)
JPY/INR 0.60(-0.53 %)
CAD/INR 62.88(-0.75 %)
HKD/INR 10.90(-0.61 %)